We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Genealogy Testing Service Relies on High-Throughput Microarray Technology

By LabMedica International staff writers
Posted on 19 May 2010
An advanced genotyping system is the basis for a new genealogic testing service that can match a wide range of family relationships within five generations. More...


Family Tree DNA (Houston, TX, USA), the first company to develop the commercial application of DNA testing for genealogical purposes, has launched a new genotyping service (The Family Finder) that will allow individuals, regardless of gender, to explore linkages to grandparents, aunts and uncles, half siblings, and first, second, third, and fourth cousins.

The test is based on Affymetrix (Santa Clara, CA, USA) Axiom genotyping technology and the associated GeneTitan analytical system. With the Axiom test, total genomic DNA (200 ng) is amplified and randomly fragmented into 25-125 base pair fragments. These fragments are purified, resuspended, and hybridized to Axiom Genome-wide human array plates. Following hybridization, the bound target is washed under stringent conditions to remove nonspecific background to minimize background noise caused by random ligation events. Each polymorphic nucleotide is queried via a multicolor ligation event carried out on the array surface. After ligation, the arrays are stained and imaged on the GeneTitan Instrument. The imaging device in the GeneTitan Instrument uses an external, high-intensity xenon lamp and dual excitation and emission filters to capture images from array plates.

The Family Finder test analyzes the DNA of two individuals using Axiom array plates containing nearly 570,000 genetic markers, including many that are relevant to genealogy. The assay system utilizes the complete Axiom genotyping solution, which includes array plates, complete reagent kits, and an automated workflow that enables scientists to process more than 760 samples per week. Family Tree DNA then analyzes the resulting data with internally developed algorithms to determine the closeness of the relationship.

"This is the most exciting genetic genealogy breakthrough since 2000, when Family Tree DNA launched its Y-DNA test to uncover relatives in the direct paternal line,” said Bennett Greenspan, CEO of Family Tree DNA. "The comprehensive, genome-wide coverage of Axiom Arrays enables us to offer consumers the most advanced genealogical test available at a price that is attractive to our customers. In addition, the automated GeneTitan system allows us to process hundreds of samples at a time with minimal hands-on time for maximum efficiency.”

"The Family Finder test represents a huge step forward for the direct-to-consumer genetic genealogy market and the application of microarray technology,” said Kevin King, CEO of Affymetrix. "Now anyone can utilize the power of the Axiom genotyping solution and the GeneTitan System to find and connect with a broader range of family members than ever before.”

Related Links:

Family Tree DNA
Affymetrix



New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Human Estradiol Assay
Human Estradiol CLIA Kit
New
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.